These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18334994)

  • 1. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.
    Lopez-Atalaya JP; Roussel BD; Levrat D; Parcq J; Nicole O; Hommet Y; Benchenane K; Castel H; Leprince J; To Van D; Bureau R; Rault S; Vaudry H; Petersen KU; Santos JS; Ali C; Vivien D
    J Cereb Blood Flow Metab; 2008 Jun; 28(6):1212-21. PubMed ID: 18334994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory.
    Benchenane K; Castel H; Boulouard M; Bluthé R; Fernandez-Monreal M; Roussel BD; Lopez-Atalaya JP; Butt-Gueulle S; Agin V; Maubert E; Dantzer R; Touzani O; Dauphin F; Vivien D; Ali C
    J Cell Sci; 2007 Feb; 120(Pt 4):578-85. PubMed ID: 17244650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
    Reddrop C; Moldrich RX; Beart PM; Farso M; Liberatore GT; Howells DW; Petersen KU; Schleuning WD; Medcalf RL
    Stroke; 2005 Jun; 36(6):1241-6. PubMed ID: 15879331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling.
    Fernández-Monreal M; López-Atalaya JP; Benchenane K; Cacquevel M; Dulin F; Le Caer JP; Rossier J; Jarrige AC; Mackenzie ET; Colloc'h N; Ali C; Vivien D
    J Biol Chem; 2004 Dec; 279(49):50850-6. PubMed ID: 15448144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity.
    Baron A; Montagne A; Cassé F; Launay S; Maubert E; Ali C; Vivien D
    Cell Death Differ; 2010 May; 17(5):860-71. PubMed ID: 19911010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional occurrence of the interaction of tissue plasminogen activator with the NR1 Subunit of N-methyl-D-aspartate receptors during stroke.
    Macrez R; Bezin L; Le Mauff B; Ali C; Vivien D
    Stroke; 2010 Dec; 41(12):2950-5. PubMed ID: 20966414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.
    Nicole O; Docagne F; Ali C; Margaill I; Carmeliet P; MacKenzie ET; Vivien D; Buisson A
    Nat Med; 2001 Jan; 7(1):59-64. PubMed ID: 11135617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo.
    Lebeurrier N; Liot G; Lopez-Atalaya JP; Orset C; Fernandez-Monreal M; Sonderegger P; Ali C; Vivien D
    Mol Cell Neurosci; 2005 Dec; 30(4):552-8. PubMed ID: 16209928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
    Roussel BD; Mysiorek C; Rouhiainen A; Jullienne A; Parcq J; Hommet Y; Culot M; Berezowski V; Cecchelli R; Rauvala H; Vivien D; Ali C
    J Cell Sci; 2011 Jun; 124(Pt 12):2070-6. PubMed ID: 21610098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of the amino terminal domain in NMDA receptor modulation.
    Huggins DJ; Grant GH
    J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subunit arrangement and function in NMDA receptors.
    Furukawa H; Singh SK; Mancusso R; Gouaux E
    Nature; 2005 Nov; 438(7065):185-92. PubMed ID: 16281028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.
    Liot G; Benchenane K; Léveillé F; López-Atalaya JP; Fernández-Monreal M; Ruocco A; Mackenzie ET; Buisson A; Ali C; Vivien D
    J Cereb Blood Flow Metab; 2004 Oct; 24(10):1153-9. PubMed ID: 15529015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly.
    Gu B; Nakamichi N; Zhang WS; Nakamura Y; Kambe Y; Fukumori R; Takuma K; Yamada K; Takarada T; Taniura H; Yoneda Y
    J Neurosci Res; 2009 Jul; 87(9):2145-56. PubMed ID: 19224577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of NR2B-selective antagonist recognition by N-methyl-D-aspartate receptors.
    Mony L; Krzaczkowski L; Leonetti M; Le Goff A; Alarcon K; Neyton J; Bertrand HO; Acher F; Paoletti P
    Mol Pharmacol; 2009 Jan; 75(1):60-74. PubMed ID: 18923063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Desmodus rotundus salivary plasminogen activator crosses the blood-brain barrier through a low-density lipoprotein receptor-related protein-dependent mechanism without exerting neurotoxic effects.
    López-Atalaya JP; Roussel BD; Ali C; Maubert E; Petersen KU; Berezowski V; Cecchelli R; Orset C; Vivien D
    Stroke; 2007 Mar; 38(3):1036-43. PubMed ID: 17325305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse galectin-1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression.
    Lekishvili T; Hesketh S; Brazier MW; Brown DR
    Eur J Neurosci; 2006 Dec; 24(11):3017-25. PubMed ID: 17156363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator and NMDA receptor cleavage.
    Matys T; Strickland S
    Nat Med; 2003 Apr; 9(4):371-2; author reply 372-3. PubMed ID: 12669038
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiated P19 cells express N-methyl-D-aspartate receptor 1 mRNA binding trans-acting proteins and four N-methyl-D-aspartate receptor 1 splice variants comparable to those in cultured fetal cortical neurons.
    Anji A; Kumari M
    J Neurosci Res; 2009 May; 87(7):1591-601. PubMed ID: 19156858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.